Bionomics Limited is reporting that their experimental drug BNC210, a novel α7 nicotinic acetylcholine receptor modulator, ...

Additional studies in collaboration with Ibañez-Tallon showed that lynx-1 altered the function of nicotinic acetylcholine receptors. Acetylcholine is a neurotransmitter that helps to activate muscles ...

Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

Mongooses and snakes are locked in an evolutionary arms race. Mongooses, with their agility, venom resistance, and protective ...

Mechanistically, antagonist-mediated blocking of NMDA receptor (hypofunctioning) leads to the excessive release of excitatory neurotransmitters (glutamate and acetylcholine) in different brain ...

Bionomics is advancing its lead drug candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the α7 nicotinic acetylcholine receptor, for the acute treatment of Social ...

According to GlobalData’s Drugs Database, the schizophrenia market remains dominated by dopamine-targeted mechanisms, such as ...

An investigational therapy for post-traumatic stress disorder (PTSD) improved symptom severity as soon as one month into a 12 ...